Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome

Rhythm · Phase 2 · Completed · Enrollment 40

NCT02311673

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Setmelanotide 0.5 mg0 participantsn/rn/rn/r0
Setmelanotide 1.5 mg0 participantsn/rn/rn/r0
Setmelanotide 2.5 mg0 participantsn/rn/rn/r0
Placebo1 participantsn/rn/rn/r0

A count stays a count. This page does not turn a count into a percent.